Both antigenic drive and genetic change play critical roles in the development of mucosa-associated lymphoid tissue (MALT) lymphoma, but neither alone is sufficient for malignant transformation, and lymphoma development critically depends on their cooperation. However, which of these different events concur and how they cooperate in MALT lymphomagenesis is totally unknown. To explore this, we investigated somatic mutations of 17 genes and immunoglobulin heavy chain variable region (IGHV) usage in 179 MALT lymphomas from various sites. We showed that: (1) there was a significant association between the biased usage of IGHV4-34 (binds to the carbohydrate I/i antigens) and inactivating mutation of TNFAIP3 [encoding a global negative regulator of the canonical nuclear factor-B (NF-B) pathway] in ocular adnexal MALT lymphoma; (2) IGHV1-69 was significantly overrepresented (54%) in MALT lymphoma of the salivary gland, but was not associated with mutation in any of the 17 genes investigated; and (3) MALT lymphoma lacked mutations that are frequently seen in other B-cell lymphomas characterized by constitutive NF-B activities, including mutations in CD79B, CARD11, MYD88, TNFRSF11A, and TRAF3. Our findings show, for the first time, a significant association between biased usage of autoreactive IGHV and somatic mutation of NF-B regulators in MALT lymphoma, arguing for their cooperation in sustaining chronic B-cell receptor signalling and driving oncogenesis in lymphoma development.
Introduction
MALT lymphoma is invariably derived from a background of chronic microbial infection and/or autoimmune disorders at diverse mucosal sites, and the antigenic drive resulting from these inflammatory disorders is thought to play a critical role in the lymphoma's development [1] . Genetically, MALT lymphoma is characterized by several genetic changes in the NF-κB signalling pathway, such as activation of the positive regulators BCL10 and MALT1 by chromosome translocation, and inactivation of the negative regulator TNFAIP3 (A20) by deletion and mutation [1] . Neither the antigenic drive nor somatic genetic change alone is sufficient for malignant transformation, and lymphoma development depends critically on their cooperation.
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MALT lymphomagenesis is totally unknown. To study this, we investigated mutations in a panel of 17 genes that are frequently mutated in B-cell lymphomas characterized by constitutive nuclear factor-κB (NF-κB) activities, and also IGH gene usage in a large cohort of MALT lymphomas from various anatomical sites.
Materials and methods

Tissue materials and DNA extraction
A total of 179 MALT lymphomas were investigated, originating from the ocular adnexa (n = 101), the salivary gland (n = 32), the stomach (n = 15), the lung (n = 11), the skin (n = 9), and other miscellaneous sites (n = 11); the ocular adnexal cases constituted the subject of previous studies [2, 3] . The use of archival tissues for research was approved by the ethics committees of the involved institutions. In each case, DNA was extracted from tumour cell-rich areas (>40%) and, where possible, non-neoplastic cells by microdissection with the QIAamp DNA MicroKit. DNA quality was assessed by polymerase chain reaction (PCR), and DNAs showing amplification of ≥300-bp genomic fragments were used for mutation screening.
Targeted sequencing by Fluidigm Access Array and Illumina MiSeq
This was performed as described previously [4] and as outlined in supplementary material, Supplementary materials and methods, with each of the DNA samples being analysed in duplicate for mutations in 17 genes, including those involved in B-cell receptor (BCR) signalling (CD79A, CD79B, and CARD11), NF-κB signalling (TNFRSF11A, TNFAIP3, and TRAF3), Toll-like receptor signalling (MYD88), plasma cell differentiation (PRDM1), histone modification (CREBBP, EP300, EZH2, MLL2, MEF2B, and KDM2B), antigen presentation (B2M and CD58), and apoptosis (TP53) (Fluidigm, San Francisco, CA, USA; Illumina, San Diego, CA, USA).
PCR and sequencing of the rearranged immunoglobulin heavy chain genes
The rearranged IGH genes were amplified by the use of BIOMED-2 VH FR1/FR2-JH primers [5] , and the dominant PCR band was purified and sequenced by use of the consensus JH and family-specific VH primers. IGHV sequences with <97% identity to the germline were considered to be significantly mutated, and those with 97-99.9% identity were considered to be minimally mutated [6] . For IGHV4-34 rearrangements, the FR1 region containing the conserved Q 6 W 7 A 24 V 25 Y 26 motif, which is essential for binding to N-acetyl-lactosamines [7, 8] , was amplified and sequenced by the use of VH leader and JH primers (supplementary material, Supplementary materials and methods). [9] . The data are based on a total of 94 cases of MALT lymphoma from the ocular adnexa (n = 63), the salivary gland (n = 13), and other sites (stomach, n = 8; lung, n = 5; skin, n = 2; small intestine, n = 1; tonsil, n = 1; and gallbladder, n = 1). The biased IGHV4-34 usage was attributable to MALT lymphoma of the ocular adnexa (10/63, 15.9%) and stomach (3/8, 37.5%). The biased IGHV1-69 usage was almost exclusively attributable to salivary gland cases (7/13, 53.9%), with the exception of a single case from the tonsil, whereas IGHV3-7 did not show any association with specific sites.
Statistical analysis
The chi-square test with Yate's correction was used to compare IGHV usage between MALT lymphoma and IgM+ memory B cells (a total of 26 144 rearranged IGH sequences from 14 healthy donors ranging in age from 18 to 87 years) [9] . Bonferroni's correction was used to account for multiple hypothesis testing. Fisher's exact test was used to test for associations between IGHV usage and various somatic mutations.
Results and discussion
Mutation profile in MALT lymphoma
Among the 17 genes investigated, TNFAIP3 was the most frequently mutated, in 34 of 179 (19%) cases, with nine cases being affected by two mutations (supplementary material, Figures S1-S3 and Table S3 ). [7, 8] . In contrast, mutations were commonly seen at the CDR2 N-linked glycosylation site (N 52 H 53 S 54 ) and FR3 K 90 L 91 S 92 residues (both highlighted in light cyan), and these mutations are thought to improve the antigen-binding affinity [10, 14] .
Mutations were present at a low frequency in the remaining 16 genes, including CD79B, CARD11, MYD88, TNFRSF11A, and TRAF3, in MALT lymphoma, regardless of their sites (supplementary material, Figures S1-S3). These findings distinguish the mutation profile of MALT lymphoma from those of other B-cell lymphomas characterized by constitutive NF-κB activation.
Biased usage of IGHV genes in MALT lymphoma
PCR and sequencing of the rearranged IGH genes were successful in 94 MALT lymphomas from the ocular adnexa (n = 63), the salivary gland (n = 13), the stomach (n = 8), the lung (n = 5), and other miscellaneous sites (n = 5). In comparison with IgM+ memory B cells from healthy donors [9] , the usage of IGHV4-34 (P < 0.0001), IGHV1-69 (P < 0.0001) and IGHV3-7 (P < 0.02) was significantly overrepresented in MALT lymphoma, with IGHV4-34 and IGHV1-69 usage retaining significance following Bonferroni correction ( Figure 1 ; supplementary material, Table S4 ). The biased IGHV4-34 usage was attributable to MALT lymphoma of the ocular adnexa (10/63, 15.9%) and stomach (3/8, 37.5%), whereas the biased IGHV1-69 usage was almost exclusively attributable to salivary gland cases (7/13, 53.9%). IGHV3-7 did not show an association with any site.
Features of IGHV4-34 rearrangements
Most of the rearranged IGHV4-34 cases (11/13, 84.6%) showed a significant level of somatic mutation (<97% identity to the germline, average 93%, range 78-100%; supplementary material, residues were spared by somatic mutation in nine cases despite their high load of somatic mutations (Figure 2 ). This finding is very similar to those of van Maldegem et al. [11] , but different from those of Zhu et al., who found mutation in five of eight cases ( Figure 2 ) [12] . The CDR2 N-linked glycosylation site (N 52 H 53 S 54 ) encoded by germline IGHV4-34 is usually unoccupied, but is often mutated in normal memory B cells and activated B-cell-like diffuse large B-cell lymphoma [10, 13] . Mutation of this germline N-linked glycosylation site appeared to help the survival of lymphoma cells that express IGHV4-34 BCR, presumably by improving the antigen-binding affinity [10] . Interestingly, mutation at this glycosylation site was seen in Interestingly, the IGHV3-7 archetypical rearrangement has also been reported previously in ocular adnexal MALT lymphoma [21] , whereas the IGHV4-59 archetypical rearrangement is seen in chronic lymphocytic leukaemia and splenic marginal zone lymphoma [22] . The gap in alignment is indicated by '−'. six of 10 (60%) IGHV4-34 rearrangements investigated (Figure 2 ). These observations are in keeping with those reported previously [11, 12] .
The FR3 K 90 L 91 S 92 residues constitute a known mutation hotspot in the IGHV4-34 rearrangement associated with primary cold agglutinin disease, and the extent of the hotspot mutation significantly correlates with the reduced haemoglobulin levels at diagnosis, indicating its importance in antigen binding [14] . In this study, mutation in the FR3 K 90 L 91 S 92 residues was seen in seven of 10 (70%) IGHV4-34 rearrangements, and all of the mutations affected the K 90 and/or S 92 residue, with six of seven mutated cases showing two mutations (Figure 2) , which is very similar to what has been described previously [11, 12] .
Features of IGHV1-69 rearrangements
Most of the rearranged IGHV1-69 cases (7/8, 87.5%) showed a significant level of somatic mutation (<97% identity to the germline, average 93%, range 88-99%; Table S3 ). Of the eight IGHV1-69 rearrangements, the complete VDJ junction sequence was obtained in six, and all utilized IGHJ4. The CDR3 sequence in each of these rearrangements showed a high identity to those of classic rheumatoid factors (RFs), with four and two matching to RF-112/113/RF-BOR and RF-WOL, respectively ( Figure 3) .
We also searched the CDR3 sequence of the remaining salivary gland cases for similarity to RFs, and this identified a further three cases with a potential RF stereotypic sequence. Two cases carried an IGHV3-7-IGHD3-22-IGHJ3 rearrangement and showed high identity to RF-M7 [15] , whereas the remaining case carried an IGHV4-59-IGHD2-15-IGHJ2 rearrangement and showed high identity to RF-MR20 (Figure 3 ) [16] .
Significant association between TNFAIP3 mutation and IGHV4-34 usage TNFAIP3 inactivation by mutation or deletion was significantly higher in MALT lymphomas with IGHV4-34 rearrangement (7/13, 54%), particularly in those of the ocular adnexa (70%), than in those utilizing other IGHV genes (16/65, 20%) (P < 0.02) (Figure 4) . Interestingly, the cases with both TNFAIP3 inactivation and IGHV4-34 rearrangement showed no evidence of mutation in the other 16 genes investigated, with the exception of a single B2M mutation (supplementary material, Table S3 ). Of the three ocular adnexal MALT lymphomas with IGHV4-34 rearrangements but absence of TNFAIP3 inactivation, one had a mutation in TNFRSF11A, one had a previously identified mutation in ABIN2 (a TNFAIP3 binding partner required for NF-κB inhibition) [2] , and one had no identifiable genetic abnormality. Intriguingly, the three gastric MALT lymphomas that harboured IGHV4-34 rearrangement showed no mutations in the 17 genes investigated, or translocations involving either BCL10 or MALT1. (supplementary material, Table S3 ).
The significant concurrence of IGHV4-34 rearrangement and TNFAIP3 inactivation in ocular adnexal MALT lymphoma suggests that the two events are most likely cooperative in lymphomagenesis (supplementary material, Figure S4 ). Engagement of IGHV4-34 BCR by autoantigen may cause chronic BCR signalling and activate the canonical NF-κB pathway. TNFAIP3 Figure 4 . Association between biased IGHV usage and TNFAIP3 (A20) inactivation in MALT lymphoma. TNFAIP3 deletion data available from a previous study were also included in the correlation analysis [2] . The upper panel shows the incidence of TNFAIP3 (A20) inactivation in MALT lymphoma according to IGHV usage, and the lower panel shows the association between TNFAIP3 (A20) inactivation and various IGHV usages. IGHV4-34 was significantly associated with TNFAIP3 inactivation, particularly in MALT lymphomas of the ocular adnexa, whereas IGHV1-69 usage was exclusive to the cases without TNFAIP3 mutation, although the difference was not statistically significant. ns, not significant.
(A20) can inactivate several NF-κB-positive regulators, including RIP1/2, TRAF6, and IKKγ, through its ubiquitin-editing activities, and negatively regulates signalling from multiple surface receptors, including BCR [17] . Thus, TNFAIP3 inactivation could potentially augment NF-κB activation triggered by chronic BCR signalling, arguing for their oncogenic cooperation (supplementary material, Figure S4 ).
In contrast, the salivary gland MALT lymphoma with IGHV1-69 rearrangement showed no TNFAIP3 mutation. We also found no evidence of mutation in KLF2, another global negative regulator of NF-κB [18] , in 32 cases of salivary gland MALT lymphoma, including those with IGHV1-69 rearrangement. The genetic changes that cooperate with BCR signalling in salivary gland MALT lymphoma remain to be investigated.
Very similar to the above observation in ocular adnexal MALT lymphoma, a significant association between inactivating mutations of KLF2 and expression of the autoreactive IGHV1-2*04 BCR is seen in splenic marginal zone lymphoma (supplementary material, Figure S4 ) [18] . Associations between distinctive gene mutations and, particularly, BCR expression is also found in hairy cell leukaemia (between MAP2K1 mutation and IGHV4-34 BCR) [19] and chronic lymphocytic leukaemia (between SF3B1 mutation and IGHV3-21 BCR in subset-2) [20] . Together, these findings suggest that this is probably a common theme in mature B-cell lymphoma, and further emphasize potential oncogenic cooperation between genetic changes and BCR signalling in B-cell lymphoma development.
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